Extract from: SYNERGY ONLINE: Bulletins and News Briefs from
The Canadian Society for International Health: csih@fox.nstn.ca
---------------------------------------------------------------------
Pan American Health Organization/World Health Organization - Vacancy
Notices
Post title: Advisor on Essential Drugs and Contraceptive Management; Level:
P.4; Post Number: .5996; Duty Station: Port-au-Prince, Haiti; Tenure: Two
years, first year probationary period; Division/Program/Office: Health
Systems and Services Development (HSP) Essential Drugs and Technology
(HSE).
Basic Salary: $45,413 at single rate; $48,824 with primary dependents (per
annum net of taxes); Post Adjustment: $15,440 at single rate; $16,660 with
primary dependents (per annum net of taxes); Hardship/Mobility: $10,148 at
single rate; $13,531 with primary dependents (per annum net of taxes).
Minimum Requirements:
Education: Postgraduate degree to at least the master's level in
pharmacology with specialization in drug policies and quality control, drug
regulations, drug supply, drug utilization, drug production and
development, pharmaceutical services, or a related subject.
Experience at the national Level: Seven years of operational experience in
the pharmaceutical field, including experience with programs and projects
related to drug policies and regulations, drug quality control, and drug
purchase, storage and distribution.
At the international level: Two years of experience in providing technical
cooperation concerning the development, management, operation or evaluation
of pharmaceutical projects and programs. Experience in logistical aspects
and management of family planning would be an asset.
Languages: Very good knowledge of French with a working knowledge of
English.
For more information, contact:
PAHO/WHO
525 Twenty-Third St., N.W., Washington, D.C. 20037 USA
Tel: 202-974-3379l; Fax: 202-974-3396; http://www.paho.org
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.